Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Specialized team assists Navajo Nation COVID-19 response

Article
3/16/2021
Military personnel wearing face mask posing for a picture

An RRRT is a small team comprised of specialized individuals that can be deployed to rural locations of the country.

Recommended Content:

COVID-19 Toolkit | Coronavirus

Army Reserve nurse assists with Federal COVID response in Arizona

Article
3/15/2021
Military personnel posing for a picture while driving a truck

Celeski brought experience in COVID-19 care from her civilian position as a registered nurse with the Veterans Affairs medical system in San Antonio.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Naval Air Facility El Centro administers COVID-19 vaccine

Article
3/12/2021
Military health personnel administering the COVID-19 vaccine

Sailors and select Department of Defense civilians at Naval Air Facility EL Centro in California began receiving their COVID-19 vaccines in early March.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

NMRTC Bremerton nurse supports the COVID-19 vaccine effort

Article
3/12/2021
Military health personnel wearing a face mask posing for a picture

Bremerton nurse oversees several hundred beneficiaries given their initial dose of COVID-19 vaccine.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Get the COVID-19 vaccine you can and get it now, Fauci and Place say

Article
3/11/2021
Military personnel wearing a face mask receiving the COVID-19 vaccine

Get the COVID-19 vaccine, whichever you can, as soon as you can is the message from Dr. Fauci and DHA chief Dr. Place

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Q&A: Are COVID-19 Vaccines Safe and Effective?

Article
3/11/2021
Military health personnel wearing a face mask and a face shield administering the COVID-19 vaccine

Military Health System provides answers to COVID-19 vaccine questions.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DOD identifies more troops to help administer COVID-19 vaccine

Article
3/9/2021
Military personnel wearing a face mask filling up syringes with the COVID-19 vaccine

The DHA supports the DoD's administering COVID-19 vaccinations at community vaccination centers around the country.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

MHS GENESIS MassVax system rolling out with COVID19 vaccines

Article
3/9/2021
Military personnel wearing face mask sitting in a line waiting for their COVID-19 vaccine

The new MHS GENESIS MassVax record-keeping tool is expediting and simplifying the process of COVID-19 vaccinations across the DOD

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS GENESIS | COVID-19 Vaccine Toolkit | MHS GENESIS

WWII soldier and his wife receive COVID-19 vaccine

Article
3/5/2021
Military personnel wearing a mask, giving the COVID-19 vaccine to a veteran wearing a mask

Beck’s arrival signals a new phase of Fort Carson’s COVID-19 vaccination efforts for TRICARE beneficiaries 75 and older.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Army Recruiter volunteers to administer COVID-19 vaccination

Article
3/2/2021
Military health personnel wearing a face mask giving someone the COVID-19 Vaccine

Army Master Sgt. Carolyn Lange has kept up her skills as a licensed practical nurse by administering COVID-19 vaccines on Fort George G. Meade in Maryland

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Toolkit | COVID-19 Vaccine Toolkit

COVID-19: DOD vaccinates more than 1 million beneficiaries worldwide

Article
3/1/2021
Military personnel wearing face mask standing in line to receive their COVID-19 Vaccine

As DOD surpasses the administration of 1 million COVID-19 vaccine shots in arms, leaders reflect on how each military treatment facility community made the success possible, despite challenges.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Toolkit | COVID-19 Vaccine Toolkit

DOD officials provide COVID-19 response update

Article
3/1/2021
Military personnel wearing a face mask handling prescription refills at a pharmacy

DoD officials present update on COVID-19 response efforts

Recommended Content:

Coronavirus | COVID-19 Toolkit | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Cardiovascular providers counter pandemic-induced sedentary lifestyle

Article
2/26/2021
Military health personnel sticking an IV in a patient's arm

COVID-19 fears likely affecting cardiovascular care but not at military medical treatment facilities.

Recommended Content:

Coronavirus | Heart Health | Medical and Dental Preventive Care Fitness | February Toolkit | Preventing Heart Disease

DOD participates in new COVID-19 antibody combination prevention trial

Article
2/23/2021
Woman gets blood drawn

Five DoD sites across the United States will be part of the STORM CHASER trial, a study to observe the efficacy of a long-lasting antibody product to prevent COVID-19 among people who have been exposed to others suffering from the disease.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Trained military personnel ready to help with COVID-19 vaccinations

Article
2/23/2021
Military health personnel wearing a mask giving the COVID-19 vaccine to a man who is also wearing a face mask

Military prepped and ready to help with civilian COVID-19 mass vaccinations

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Immunizations
<< < 1 2 3 4 5  ... > >> 
Showing results 16 - 30 Page 2 of 22

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.